Resource Center
Gain inSIGHT into an Immunocompromised Patient’s T Cell Immune Response featuring: CMV & SARS-CoV-2
In this webinar, Drs. Raval, Khawaja, and Kleiboeker discuss advancements in virus-specific T-cell immunity, focusing on CMV and SARS-CoV-2. Dr. Raval shares insights on using CMV T Cell Immunity panels in heart transplant patients, Dr. Khawaja covers CMV cellular immunity in hematopoietic cell transplant recipients, and Dr. Kleiboeker introduces the SARS-CoV-2 inSIGHT T Cell Immunity test and future innovations in T cell immunity testing.
Featured Resource
Immunity Testing: CMV in Lung Transplant Patients
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.
Search the Eurofins Viracor online test directory
for the most up-to-date assay offerings and information
Test Menu